Subscribe to Get Prostate Cancer News

Hot SHEET 2019

Made possible by charitable contributions from


 - Thank You!


Our monthly newsletter, the Hot SHEET, highlights the latest in treatment strategies as well as emerging treatments. The Hot SHEET is distributed free at chapter support group meetings, and is available in PDF on the Us TOO web site.

Hot SHEET Personal Subscriptions Now Available

If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office. Download and print a subscription order form or order online.

  • Prostatectomy Beats Active Surveillance Long Term – or Does It?
  • Is No Surgery Feasible in Gleason 9 and 10 PCa?
  • Prostate Cancer Risk Lower in Long-Term Users of Lipid-Lowering Drugs
  • YouTube Videos Often Mislead on Prostate Cancer
  • Doc Moyad’s No Bogus Science: “Are Fish Oil Results a Little Fishy?!”
  • ADT May Be Less Beneficial for Gleason Score 9 to 10 Prostate Cancer
  • Doctor Chodak’s Bottom Line
  • Index of Articles Published in the 2018 Hot SHEET
  • RP Beats Surveillance, or Does It?
  • Overactive Bladder Linked to ADT for Prostate Cancer
  • New, Quicker Test to Assess Risk of PCa Metastasis
  • Short- vs. Intermediate-Term AS with RT & Zoledronic Acid
  • Doc Moyad’s Column: “Restaurants = Weight Gain?!”
  • PCa Risk Higher in Men with Inflammatory Bowel Disease
  • Hypofractionated RT & Pca
  • Combination Strategy IDs Pca
  • Gleason 6 PCa More Lethal in Black Men
  • Gold Nanoparticles Could Destroy Prostate Cancer
  • Survival - Black vs. White Men Receiving Docetaxel
  • Surrogate Marker for ADT
  • Doctor Chodak’s Bottom Line
  • Does Castrate in Prostate Cancer Need Revision?
  • Adjuvant Docetaxel No Help in High-Risk Prostate Cancer
  • AS Safe for Prostate Cancer Patients Under 60 Years Old
  • Time Interval to Biochemical Failure – Surrogate End Point?
  • PCa Death Risk Linked to Post EBRT Time to PSA Nadir
  • Doc Moyad’s Column: “Follow Breast Cancer for Lifestyle?!”
  • Fusion Biopsies in AS Predict Prostate Cancer Progression
  • QoL But Sexual Dysfunction Common After Prostate Cancer
  • Low Carb Diet & Walking May Ease Adverse Effects of ADT
  • Doctor Chodak’s Bottom Line
  • Adding MRI Does Not Boost Prostate Cancer Upgrading
  • Active Surveillance for Prostate Cancer Triples in U.S.
  • Abiraterone & Mortality Risk from Cardiovascular Disease
  • Darolutamide Results Promising in Nonmetastatic PCa
  • Phase III Trial of PROSTVAC Stopped Early Due to Futility
  • Stereotactic Body Radiotherapy Shows Long-Term Safety in PCa
  • Doc Moyad's No Bogus Science: "The Secret to Dog’s Long Life"
  • Radiological Agent Promising in Heavily-Treated mCRPC
  • Enzalutamide Plus ADT for Advanced Prostate Cancer
  • Minimal Benefit of Aspirin Post-Prostate Cancer Diagnosis
  • Doctor Chodak’s Bottom Line